American Vietnamese Biotech Incorporation

HNX:AMV Stock Report

Market Cap: ₫511.3b

American Vietnamese Biotech Incorporation Past Earnings Performance

Past criteria checks 1/6

American Vietnamese Biotech Incorporation's earnings have been declining at an average annual rate of -41.6%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been declining at an average rate of 21.1% per year. American Vietnamese Biotech Incorporation's return on equity is 0.8%, and it has net margins of 6.9%.

Key information

-41.6%

Earnings growth rate

-52.4%

EPS growth rate

Medical Equipment Industry Growth12.3%
Revenue growth rate-21.1%
Return on equity0.8%
Net Margin6.9%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How American Vietnamese Biotech Incorporation makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

HNX:AMV Revenue, expenses and earnings (VND Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23196,10713,58116,8950
30 Sep 23209,69711,86316,3010
30 Jun 23252,81113,04617,1240
31 Mar 23277,05545,00416,2060
31 Dec 22281,81853,93115,4780
30 Sep 22296,02786,36016,2410
30 Jun 22273,138114,49716,6390
31 Mar 22232,77987,62315,0870
31 Dec 21223,84382,24014,0280
30 Sep 21182,32259,36912,0680
30 Jun 21140,80236,49710,1070
31 Mar 21151,11757,2779,2330
31 Dec 20161,43178,0578,3580
30 Sep 20310,160177,99910,0980
30 Jun 20402,892222,30311,1240
31 Mar 20444,184220,13712,2800
31 Dec 19487,382219,84211,7100
30 Sep 19593,630228,9698,0850
30 Jun 19582,905239,8905,1660
31 Mar 19535,005242,1023,3970
31 Dec 18450,796215,0982,9010

Quality Earnings: AMV has high quality earnings.

Growing Profit Margin: AMV's current net profit margins (6.9%) are lower than last year (19.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AMV's earnings have declined by 41.6% per year over the past 5 years.

Accelerating Growth: AMV's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: AMV had negative earnings growth (-74.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (0.02%).


Return on Equity

High ROE: AMV's Return on Equity (0.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.